Investing.com - Albireo Pharma reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Albireo Pharma announced earnings per share of $-1.92 on revenue of $9.83M. Analysts polled by Investing.com anticipated EPS of $-2.08 on revenue of $8.47M.
Albireo Pharma shares are down 16% from the beginning of the year and are trading at $22.15 , down-from-52-week-high.
Albireo Pharma follows other major Healthcare sector earnings this month
Albireo Pharma's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar